W1092 Exocrine and Endocrine Gastric Mucosal Changes Under Medical or Surgical Antireflux Therapy. Results of a 5-Yr Follow up in the Lotus Trial

Roberto Fiocca(Alleanza Contro il Cancro), Lars Lundell(Karolinska Institutet), Göran Långström, Luca Mastracci(Ospedale Policlinico San Martino), Tore Lind(Skaraborg Hospital), Jean–Paul Galmiche(Centre Hospitalier Universitaire de Nantes), Christian Ell(Johannes Gutenberg University Mainz), Stephen E. Attwood(Durham University), Anna Reveman, Jan Gunnar Hatlebakk(Haukeland University Hospital)

Gastroenterology

April 28, 2010

10.1016/s0016-5085(10)62991-5

Cited by 2

Related Papers

Esophageal eosinophilia with dysphagia

|Digestive Diseases and Sciences|1993|889

Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study

|Helicobacter|1996|575

A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.

|Gastroenterology|2004|526

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

|Gastroenterology|1999|433

Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

|Gastroenterology|2012|378